13Feb
Ahead of the pack: US M&A 2019: Biotech boosts US healthcare M&A in 2019
The healthcare sector (incorporating pharma, medical and biotech) has seen M&A valued at US$256.5 billion across 645 deals in 2019. This is a decrease of 9 percent by volume, but an increase of 121 percent by value....
By:
White & Case LLP
Related
During the previous economic expansion, retail faced an uphill battle. The current recession tripled...
Read More >
If an employee asks for time off to attend a meeting at his or her child’s school, is that covered ...
Read More >
Despite accumulating a vast, historic pile of capital for acquisitions, private equity has moderated...
Read More >
Through the Supreme Decree N° 014-2019-MIMP, the Ministry of Women and Vulnerable Populations has re...
Read More >
Seyfarth Synopsis: New Jersey Has Joined California and New York as the Third State to Formally Amen...
Read More >
The coronavirus pandemic has upended nearly every corner of the world — and shareholder activism is...
Read More >